Dietary and drug therapies for primary prevention of atherosclerosis;Prévention primaire nutritionnelle et médicamenteuse de l'athérosclérose

Revue de Medecine Interne

Volumn 20, Issue SUPPL. 3, 1999, Pages 360-370

  Monnier, L ^a   Avignon, A ^a   Colette, C ^a   Piperno, M ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Atherosclerosis; Drug strategies; Nutritional recommendations; Primary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERIOSCLEROSIS; BLOOD; CALORIC INTAKE; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DIET THERAPY; FEEDING BEHAVIOR; HUMAN; HYPERCHOLESTEROLEMIA; NUTRITION; PRIMARY PREVENTION; REVIEW; RISK FACTOR;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COST-BENEFIT ANALYSIS; ENERGY INTAKE; FIBRINOLYTIC AGENTS; FOOD HABITS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; NUTRITION PHYSIOLOGY; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; RISK FACTORS;

EID: 0013345399     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996 ; 94 : 2013-20.
2. Beisiegel U, ST Clair RW. An emerging understanding of the interactions of plasma lipoproteins with the arterial wall that leads to the development of atherosclerosis. Curr Opin Lipidology 1996 ; 7 : 265-8.
3. Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidology 1997 ; 8 : 268-74.
4. Kruth HS. The fate of lipoprotein cholesterol entering the arterial wall. Curr Opin Lipidology 1997 ; 8 : 246-52.
5. National Cholesterol Education Program. Report of the expert panel on population strategies for blood cholesterol reduction. Arch Intern Med 1991 ; 151 : 1071-84.
6. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994 ; 89 : 1333-1445.
7. Castelli WB, Garrison RJ, Wilson PNF, Abbott RD, Kalousdian S, Kannel WB. The incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. J Am Med Assoc 1986 ; 256 : 2835-8.
8. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor international trial risk factor changes and mortality results. J Am Med Assoc 1982 ; 248 : 1465-76.
9. Assmann G, Schulte H. The Prospective Cardiovascular Muenster (PROCAM) Study: prevalence of hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988 ; 116 : 1713-24.
10. Avignon A, Boegner C, Monnier L. Insuline, glucagon, cœur et vaisseaux. In : Hormone, Cœur et Vaisseaux. Paris : INSERM ; 1997. p. 319-79.
11. Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997 ; 20 : 1744-66.
12. Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the Finnish mental hospital study. Int J Epidemiol 1979 ; 8 : 99-118.
13. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking on the incidence of coronary heart disease. Lancet 1981 ; 2 : 1303-10.
14. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, et al. Serum cholesterol level and mortality: findings for men screened in the Multiple Risk Factor Interventional Trial. Arch Intern Med 1992 ; 152 : 1490-1500.
15. World Hearth Organisation European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease. Lancet 1986 ; 1 : 869-72.
16. Frantz ID, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, et al. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arterioscler Thromb Vase Biol 1989 ; 9 : 129-35.
17. Strandberg TE, Salomaa VV, Naukkarinen VA. Long term mortality after 5 year multifactorial primary prevention of cardiovascular diseases in middle-aged men. J Am Med Assoc 1991 ; 266 : 1225-9.
18. De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I. Mediterranean alpha-linolenic acid - risk diet in secondary prevention of coronary heart disease. Lancet 1994 ; 343 : 1454-9.
19. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I : Reduction in incidence of coronary heart disease. J Am Med Assoc 1984; 251 : 351-364.
20. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II : The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984 : 251 : 365-74.